7th Conference on Experimental and Translational Oncology - CETO

Last Modified: October 26, 2012

Dates: April 20-24, 2013
Location: Portoroz, Slovenia

Web Page URL: http://www.ceto.si

Topics Covered: Tumor progression, Invasion and metastases, Biomarkers, New drugs and therapeutic targets, Delivery systems in cancer, Cellular therapy, Biomedical applications of electroporation, Environmental carcinogens and cancer prevention.

Objectives: The aim of the Conference is to promote the achievements of basic and clinical investigators on mechanisms of tumor initiation, development and progression as well as the introduction of new strategies for detection, prevention and treatment of cancer.

Who Should Attend: Resesarcher in the field of cacner treatment, Oncology specialists

Agenda: The Conference is an ideal place for a gathering of young prospective scientists and established colleagues, to ensure the collaboration between academic and industrial institutions and to establish new contacts between scientists from different regions.

Registration Information: Registration fee is 350 € (20% VAT included) and includes: Entrance to the conference, Program and Abstract book Refreshment during breaks Welcome reception, Conference dinner Entrance to the swimming pools Certificate of attendance For students under age of 28 the registration fee is 280 €. For accompanying persons the fee is 100 € and includes social events, entrance to the swimming pools. One-day registration fee is 100 € and includes entrance to the conference, Program and Abstract book and refreshment during breaks.

Fees: Regular: 350€, Students under age 28: 280€, Accompanying persons: 100€, One-day registration: 100€

Continuing Education: No

Audience: HCP


7 Tips for Giving Smart on #givingtuesday
by Christina Bach, MSW, LCSW, OSW-C
November 25, 2015

Related News

RAD51 Mutations Confer Moderate Risk of Ovarian Cancer

Aug 16, 2015

RAD51C and RAD51D deleterious mutations linked to increased risk of epithelial ovarian cancer

AACR: Conference Offers Look at Cancer Drugs in Pipeline

Nov 25, 2015

International conference presentations include leukemia drug screening, olaparib, cediranib

Yoga May Help Maintain Quality of Life for Prostate Cancer Patients

Nov 22, 2015

Small study shows those undergoing radiation therapy had fewer side effects, less fatigue